Dicerna Enters Into Research Collaboration, License Agreement With Kyowa Hakko Kirin
Dicerna Pharmaceuticals (Dicerna) and Kyowa Hakko Kirin have entered into a research collaboration and license agreement for the research, development and commercialisation of drug delivery systems and DsiRNA
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.